Clinical Trial Update: Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bendamustine plus rituximab in older patients with previously untreated diffuse large B-cell lymphoma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• Treanda (Bendamustine)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Diffuse Large B-Cell Lymphoma, Lymphoma, Diffuse Large-Cell | Phase 2 | Status: COMPLETED | Results posted: 2017-04-26